AbbVie
ABBV
ABBV
2,221 hedge funds and large institutions have $82.6B invested in AbbVie in 2020 Q1 according to their latest regulatory filings, with 145 funds opening new positions, 1,008 increasing their positions, 838 reducing their positions, and 134 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 2,241 → 2,221 (-20)
13% less capital invested
Capital invested by funds: $94.8B → $82.6B (-$12.1B)
20% less call options, than puts
Call options by funds: $1.4B | Put options by funds: $1.75B
Holders
2,221
Holding in Top 10
150
Calls
$1.4B
Puts
$1.75B
Top Buyers
| 1 | +$1.13B | |
| 2 | +$397M | |
| 3 | +$342M | |
| 4 |
Bank of New York Mellon
New York
|
+$265M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$231M |
Top Sellers
| 1 | -$2.85B | |
| 2 | -$399M | |
| 3 | -$237M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$222M |
| 5 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$195M |